جست‌وجوی استاد و پژوهشگر

• Cancer epidemiology
• State cancer registry operations
• Cancer disparities and etiology
• +۱۰ مورد دیگر

Xiao-Cheng Wu is a Professor in the Department of Epidemiology at Louisiana State University Health Sciences Center New Orleans, School of Public Health and Tropical Medicine. He serves as the Director of the Louisiana Tumor Registry (LTR) and has been the LSU Principal Investigator for the NCI-SEER since 2014 and CDC-NPCR funding initiatives since 2015. With over 25 years of dedicated service to the Louisiana Tumor Registry, Dr. Wu has established himself as a leading expert in cancer registry operations and epidemiological research. Dr. Wu's research focuses on several critical areas in cancer epidemiology, including cancer disparities and etiology, cancer screening policy and evaluation of screening effectiveness, patterns and quality of cancer care, health-related quality of life for cancer patients, disparities in cancer outcomes, and social determinants of cancer prevention, early detection, treatment, and outcome. His work extensively examines how socioeconomic factors influence cancer outcomes, with particular attention to vulnerable populations in Louisiana and across the United States. He has pioneered research utilizing the SEER-linked Virtual Tissue Repository to support biospecimen research and has worked to enhance population-based cancer registry data through linkages with electronic medical records and other health data sources. Dr. Wu's extensive publication record demonstrates his leadership in cancer epidemiology research, with numerous studies examining racial and socioeconomic disparities in cancer outcomes, the impact of healthcare policies like Medicaid expansion on cancer treatment access, and the development of innovative methods for analyzing cancer registry data. His research consistently addresses critical issues in cancer control and prevention, with a strong emphasis on translating epidemiological findings into actionable public health interventions. As a leader in the field, he has served on the North American Association of Central Cancer Registries' Research and Data Use Steering Committee and chaired the Research Application Review Workgroup, contributing significantly to national cancer surveillance efforts. Dr. Wu has authored or co-authored over 200 peer-reviewed manuscripts, demonstrating his prolific contributions to the scientific literature. His work has been supported by prestigious organizations including the NCI, NIH, CDC, PCORI, and AHRQ, reflecting the significance and impact of his research. He has played pivotal roles as the Louisiana Principal Investigator for numerous multi-center research studies examining patterns of care, patient-reported outcomes, and biospecimen research. His leadership extends to local initiatives such as the Data Committee of the Taking Aim at Cancer in Louisiana project and the Louisiana Vital Records Review Panel, where he helps shape state-level cancer control strategies.

Teresa Wagnerمشاهده پروفایل

دانشیار

• Health Literacy
• Public Health
• Maternal Health
• +۳ مورد دیگر

Dr. Teresa Wagner is an Associate Professor in the College of Public Health at the University of North Texas Health Science Center (UNTHSC), with a joint appointment in the Department of Health Administration and Health Policy. She also serves as Director of the UNTHSC Texas State Certified Community Health Worker Training Center and holds cross-appointments in the College of Nursing and College of Health Professions. Her academic credentials include a Doctorate in Public Health (DPH) from UNTHSC, a Master’s in Nutrition from Texas Woman’s University, and a Bachelor’s in Dietetics from Texas Christian University. Her research focuses on health literacy, organizational health communication, maternal mortality, and rural health inequities. She has led 15 sponsored projects, including initiatives funded by the NLM, City of Fort Worth, and private entities like Yumlish. Her work emphasizes training community health workers and improving health outcomes through literacy-focused interventions. Notable awards include the 2024 Texas Distinguished Dietitian Award, 2023 UNTHSC Faculty Achievement Award, and the 2018 Texas Health Literacy Hero Award. She teaches courses on health literacy, patient safety, and nutrition across multiple colleges at UNTHSC. Education: DPH (UNTHSC), MS (Texas Woman’s University), BS (Texas Christian University) Key Projects: Includes frameworks for health literacy measurement, rural health equity studies, and CHW certification programs. Her publications span health literacy frameworks, maternal health interventions, and rural health challenges, with recent focus on AI ethics in healthcare and postpartum app usability.

• Neurodegenerative Diseases
• Alzheimer's Disease
• Cognitive Neuroscience
• +۵ مورد دیگر

Zoe Arvanitakis, MD, MS, is the Acting Chairperson of the Department of Neurological Sciences at Rush Medical College, Rush University, and Medical Director of the Rush Memory Clinic at the Rush Alzheimer’s Disease Center. She holds a Professor rank in Neurological Sciences, specializing in cognitive neurology and dementia. Her expertise spans clinical care, research, and education with over two decades of experience. Dr. Arvanitakis earned her MD and an MS in Clinical Research with subspecialization in epidemiology. Her research focuses on neurodegenerative, vascular, and metabolic cognitive disorders, leveraging large-scale epidemiological studies and clinical-pathologic cohorts. She leads NIH-funded grants and clinical trials, investigating Alzheimer’s disease mechanisms, insulin signaling, and lifestyle interventions. Key research interests include Alzheimer’s pathology, brain insulin resistance, and vascular risk factors. She co-edited a medical textbook and serves on national panels, including the NIH Neurological, Aging and Musculoskeletal Epidemiology study section. Awards include the Rush Faculty Award for Excellence in Mentoring and recognition from the American Academy of Neurology. She collaborates across disciplines, integrating clinical, neuroimaging, and biospecimen data to advance understanding of aging-related diseases. Her work emphasizes preventive strategies, including the MIND diet and multidomain lifestyle interventions targeting cognitive decline in elderly populations.

Peter Tarczy-Hornochمشاهده پروفایل

استاد

• Biomedical Informatics
• Data Integration
• Translational Bioinformatics
• +۵ مورد دیگر

Peter Tarczy-Hornoch is Professor and Chair of Biomedical Informatics and Medical Education at the University of Washington, with adjunct appointments in Pediatrics and Computer Science. He directs the Precision Medicine Informatics Group (PMIG) and leads multiple national initiatives including the NIH NLM-funded Biomedical and Health Informatics Research Training Program. His affiliations span advisory roles for ClinGen, CTSA centers, and editorial boards of major informatics journals. His research integrates data science with clinical applications, focusing on: Translational bioinformatics infrastructure Genomic and electronic health record integration Pharmacogenomic decision support systems Biospecimen acquisition frameworks Comparative effectiveness research methodologies Recent publications demonstrate emphasis on implementing genomic medicine in clinical workflows, COVID-19 informatics, and optimizing learning health systems. Honors include: Fellow of the American College of Medical Informatics (FACMI) He mentors graduate students and postdocs while leading funded projects such as: NIH Clinical Sequencing Exploratory Research (CSER) Consortium coordination Precision Medicine Informatics Group initiatives AHRQ-funded pharmacogenomics implementation studies CTSA Biomedical Informatics Core development His PMIG lab develops tools for phenotype extraction, genomic data integration, and clinical decision support, collaborating with healthcare systems nationwide.

• Neuropathology
• Alzheimer's Disease
• Brain Tumors
• +۷ مورد دیگر

Anita Huttner, MD is an Associate Professor of Pathology at Yale School of Medicine with extensive affiliations across Yale's research ecosystem. She holds primary appointments in the Department of Pathology and participates in numerous specialized research centers including the Alzheimer's Disease Research Center (ADRC), Brain Tumor Center, Genomics, Genetics, and Epigenetics Program, and Yale Cancer Center. Her dual expertise spans neuropathology and molecular diagnostic pathology, creating a unique interdisciplinary approach to understanding brain diseases. Dr. Huttner's research focuses on neurological disorders with particular emphasis on Alzheimer's disease, brain tumors, and epilepsy. She employs innovative techniques including subcellular proteomics, induced pluripotent stem cell (iPSC) modeling, and advanced imaging analysis to investigate disease mechanisms. Her work bridges traditional microscopic examination with modern genomic analysis, allowing her to incorporate genetic sequencing results into visual tumor analysis. Recent publications demonstrate her leadership in identifying biomarkers for neurological conditions and developing novel diagnostic approaches for brain disorders. Analysis of Dr. Huttner's recent publications (2023-2025) reveals a strong focus on Alzheimer's disease mechanisms, brain tumor classification using advanced imaging techniques, and neurological conditions like Tourette Disorder and epilepsy. Her work frequently employs cutting-edge methodologies including single-cell transcriptomics, subcellular proteomics, and AI-based analysis of medical imaging. These publications appear in high-impact journals such as Nature Neuroscience, Nature Aging, and Biological Psychiatry, demonstrating the significance of her contributions to the field. Averill A. Liebow Award for Excellence in the Teaching of Pathology Residents (2009) Nomination for the Alice Bohmfalk Teaching Award in Basic Science (2005) Dr. Huttner maintains an active research program with numerous collaborations across Yale and beyond. Her work involves both basic science investigations and clinical applications, with a particular focus on translating laboratory findings into improved diagnostic approaches and potential treatments. She serves as a Sub Investigator for the SV2A PET Imaging clinical trial focused on epilepsy patients, demonstrating her commitment to translational research that directly impacts patient care. Her mentorship extends to pathology residents, with recognition for excellence in teaching. Based at the Brady Memorial Laboratory at Yale, Dr. Huttner's work integrates multiple research approaches to understand brain pathology at both cellular and molecular levels. Her laboratory investigations focus on recreating brain disorders using stem cell technology to model conditions like epilepsy and Alzheimer's disease, with the ultimate goal of developing better treatments for neurological conditions and brain tumors.